Working… Menu

A Study in Recurrent Glioblastoma (GB)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01582269
Recruitment Status : Active, not recruiting
First Posted : April 20, 2012
Last Update Posted : December 4, 2018
Information provided by (Responsible Party):
Eli Lilly and Company

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : July 26, 2014
Estimated Study Completion Date : December 31, 2019
Certification/Extension First Submitted : September 29, 2014